Long-term outcomes after carbon ion-radiotherapy for oral mucosal malignant melanoma
نویسندگان
چکیده
منابع مشابه
Long-term outcomes after carbon-ion radiotherapy for oral mucosal malignant melanoma
Oral mucosal malignant melanoma (OMM) is extremely rare and has a poor prognosis. Owing to its rarity, it has not yet been possible to establish an optimal treatment modality. The objective of this study was to evaluate the long-term efficacy of carbon-ion radiotherapy (C-ion RT) for OMM. Between 1997 and 2013, 19 patients with OMM were treated with C-ion RT alone. Patient ages ranged from 44 t...
متن کاملOral mucosal melanoma treated with carbon ion radiotherapy: a case report
BACKGROUND Oral mucosal melanoma is a rare disease with a relatively poor prognosis. Carbon ion radiotherapy has been shown to be effective against radiotherapy-resistant tumors owing to its excellent dose concentration and high biological effect. CASE PRESENTATION Our patient was a 66-year-old Japanese man with oral mucosal melanoma of his right maxillary gingiva (T4aN0M0). He received carbo...
متن کاملMalignant Mucosal Melanoma of the Maxillary Sinus
Sinus mucosal malignant melanoma, is a rare type of melanoma with poor prognosis which is usually occurred in the adults. This is a rare case of a 33-year-old man presenting 2-week-long headache and nasal obstruction with the emphasis on the importance of Immunohistochemical staining to help the diagnosis.
متن کاملOral mucosal melanoma: a malignant trap
Oral mucosal melanomas are highly malignant tumors. The 'chameleonic' presentation of a mainly asymptomatic condition, the rarity of these lesions, the poor prognosis and the necessity of a highly specialized treatment are factors that should be seriously considered by the involved health provider. We present the case of a 75-year-old man who was referred to the Ear, Nose and Throat department....
متن کاملExperience of long-term management for osteoradionecrosis of the maxilla after carbon ion radiotherapy
Materials and methods: From April 1997 to April 2006, 239 patients with the head and neck cancers were treated with CIRT with a dose of 57.6 GyE per 16 fractions. Patients whose alveolar process and palatine process of maxilla had been irradiated more than 10% of the prescribed dose were selected. We exclude the cases of after operation therapy and after radiation therapy. For this study, we em...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Japanese Journal of Oral and Maxillofacial Surgery
سال: 2018
ISSN: 0021-5163,2186-1579
DOI: 10.5794/jjoms.64.237